Drug
Insulin Detemir
Insulin Detemir: highest development phase Phase 3, developed by Novo Nordisk. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| insulin detemir NCT00504673 | Phase 3 | Diabetes |
| insulin detemir NCT01497600 | Phase 1 | Diabetes |
Latest
No recent events.
Follow Insulin Detemir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.